Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
DaVita Community
NYSE:DVA Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
DaVita
Popular
Undervalued
Overvalued
Community Investing Ideas
DaVita
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Kidney Smart And IKC Programs Will Deliver Holistic Kidney Care In Partnership With CMS
Key Takeaways DaVita's expansion into comprehensive kidney care and international markets is strategically positioning the company for future revenue and earnings growth. Focus on enhancing collection performance and share repurchase strategy aims to improve net margins and achieve strong earnings per share growth.
View narrative
US$164.57
FV
11.1% undervalued
intrinsic discount
4.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
DVA
DVA
DaVita
Your Fair Value
US$
Current Price
US$146.28
21.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
16b
2015
2018
2021
2024
2025
2027
2030
Revenue US$15.9b
Earnings US$1.2b
Advanced
Set Fair Value